Order against 75F40121D00009 qiagen IDIQ for purchase of molecular biology reagents.

Ended Awarded Last action

Contract number
75F40126F19008
Awardee
Awarding agency
Obligated
$137,961

Award facts

Contract value 100% obligated
$137,961.14 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration issued a delivery order to Qiagen, LLC on June 1, 2026, with a ceiling value of $137,961.14, against an IDIQ for purchase of molecular biology reagents under contract 75F40121D00009.

The order is firm fixed price with an ultimate completion date of September 30, 2026. Place of performance is Silver Spring, MD 20993. No set-aside was used for this order.

Quick answers

Who was awarded contract 75F40126F19008?

75F40126F19008 was awarded to Qiagen, LLC by Food and Drug Administration (Department of Health and Human Services) on June 1, 2026.

How much is contract 75F40126F19008 worth?

The government has obligated $137,961 on 75F40126F19008.

Is contract 75F40126F19008 an order under another contract?

Yes. 75F40126F19008 is a delivery order under 75F40121D00009, an indefinite delivery contract.

Was contract 75F40126F19008 competed?

The extent of competition for 75F40126F19008 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award